Vierboom, M P M <br/><br/>
Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis.  [electronic resource] 

 -  Clinical and experimental immunology  Mar 2016 
 - 405-18 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2249 
<br/><br/><label>Standard No.: </label>10.1111/cei.12739  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept--administration & dosage<br/>Animals<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Experimental<br/>Arthritis, Rheumatoid--drug therapy<br/>Autoimmunity--drug effects<br/>C-Reactive Protein--metabolism<br/>CD28 Antigens--antagonists & inhibitors<br/>Collagen--immunology<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Interleukin-6--blood<br/>Lymphocyte Activation--drug effects<br/>Macaca mulatta<br/>Male<br/>T-Lymphocytes--drug effects<br/>Treatment Outcome